Zoetis Inc. (ZTS)
Pharmaceutical Preparations · Pharmaceutical Preparations · NYSE
$76.17
-1.40%
Investru Score
60.5 / 100
Good
Why is ZTS moving?
ZTS is down 1.40% today, amid an otherwise sideways trend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Want the complete AI research memo? Unlock full stock analysis →
Score breakdown
- Financial Quality
- 79
- Growth
- 31
- Profitability
- 59
- Balance Sheet
- 41
- Valuation
- 83
- Momentum
- 72
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- 21.6%
- ROE
- 80.2%
- FCF Margin
- 24.1%
- Free Cash Flow (TTM)
- $2.3B
- Earnings Quality (OCF ÷ Net Income)
- 1.1x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- 11.8x
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- 1.2x
- Company Median PEG
- 1.2x
- Price / Sales
- 3.4x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 7.0%
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $1.65
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-30Filed 2026-08-06
- 10-Q · Q1 FY26 · period ended 2026-03-31Filed 2026-05-07
- 10-K · FY25 · period ended 2025-12-31Filed 2026-02-12
- 10-Q · Q3 FY25 · period ended 2025-09-30Filed 2025-11-04
- 10-Q · Q2 FY25 · period ended 2025-06-30Filed 2025-08-05
- 10-K · FY24 · period ended 2024-12-31Filed 2025-02-13
- 10-K · FY23 · period ended 2023-12-31Filed 2024-02-13
- 10-K · FY22 · period ended 2022-12-31Filed 2023-02-14
- 10-K · FY21 · period ended 2021-12-31Filed 2022-02-15
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $32.4B · 52-week range $71.00–$155.15 · market data as of Sep 2, 2026, 4:03 PM ET · latest SEC filing: 2026-08-06
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze ZTS with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.